Sinopharm Positions Itself For MNCs That May Need To Change Sales Models In China
This article was originally published in PharmAsia News
Executive Summary
China’s largest pharmaceutical distributor has built up a web of subsidiaries to expand its manufacturing and distribution capabilities. The company said global pharma companies may need to change their sales models in China as a result of corruption probes and it wants to be first in line to help.